Bradley Monk
Gynecologic Oncology · West Palm Beach, FLNPI 1487734646
Payments from drug & device makers
Across 3,137 payments — averaging $3337.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2.9M
- Merck$1.5M
- Novartis$1.2M
- Incyte Corporation$1.1M
- AstraZeneca$733K
- GSK$675K
- plus $2.3M from 54 others
Across 51 payments — averaging $1558.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$64K
- Regeneron$11K
- Pfizer$2K
- F. Hoffmann-la Roche AG$1K
- Novartis Pharma AG$346
- Seagen Inc.$345
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$10,471,278 in reported general payments places this provider in the 95th percentile of 117 gynecologic oncology providers in Florida.
Other gynecologic oncology in West Palm Beach
- Howard GoodmanWest Palm Beach$43K
- Christopher McCannWest Palm Beach$32K
- Matthew SchlumbrechtMiami$16.7M
- Brian SlomovitzFort Lauderdale$13.9M
- John DiazMiami$3.7M
- Robert HollowayOrlando$3.1M
- Robert WenhamTampa$2.9M
- Hye Sook ChonTampa$2.4M
- Beverly LongSarasota$1.9M
- Martin MartinoJacksonville$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.